...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: NFK meeting
5
Feb 19, 2020 03:26PM
4
Feb 19, 2020 03:32PM
4
Feb 19, 2020 03:35PM
2
Feb 19, 2020 03:37PM
2
Feb 19, 2020 04:18PM
4
Feb 19, 2020 04:26PM
1
Feb 19, 2020 05:09PM
3
Feb 19, 2020 05:19PM
2
Feb 19, 2020 06:36PM
2
Feb 19, 2020 06:56PM
4
Feb 19, 2020 06:58PM
3
Feb 19, 2020 08:19PM
2
Feb 19, 2020 11:35PM
8
Feb 19, 2020 11:50PM
2
Feb 20, 2020 07:35AM
3
Feb 20, 2020 08:06AM
3
Feb 20, 2020 08:19AM
7
Feb 20, 2020 08:24AM
1
Feb 20, 2020 08:41AM
4
Feb 20, 2020 08:48AM
3
Feb 20, 2020 08:48AM
2
Feb 20, 2020 08:52AM
2
Feb 20, 2020 08:57AM
3
Feb 20, 2020 09:14AM
2
Feb 20, 2020 09:47AM
2
Feb 20, 2020 09:53AM
2
Feb 20, 2020 09:56AM
3
Feb 20, 2020 10:02AM

We saw that the placebo part of the CKD group in the BETonMACE trial had a reduction of eGFR,...

Can we safely assume that that is the norm for <60 eGFR diabetic patients,... over a 3 year period we see a real reduction in eGFR.

We saw a 5% reduction in the phase 2 trials.

If so,... we saw a flat eGFR in the total BETonMACE population,... so if we can assume a fall in eGFR for the CKD placebo group,... we must assume an increase in the treated CKD group to bring the eGFR back to flat for the total BETonMACE population.

3
Feb 20, 2020 10:21AM
3
Feb 20, 2020 10:49AM
4
Feb 20, 2020 11:22AM
4
Feb 20, 2020 11:38AM
1
Feb 20, 2020 12:15PM
2
Feb 20, 2020 12:26PM
2
Feb 20, 2020 12:29PM
3
Feb 20, 2020 01:31PM
3
Feb 20, 2020 01:34PM
3
Feb 20, 2020 01:40PM
2
Feb 20, 2020 01:40PM
5
Feb 20, 2020 01:41PM
4
Feb 20, 2020 01:50PM
9
Feb 21, 2020 01:14AM
7
Feb 21, 2020 07:44AM
6
Feb 21, 2020 07:48AM
5
Feb 21, 2020 08:35AM
9
Feb 21, 2020 02:59PM
2
Mar 08, 2020 05:10PM
Share
New Message
Please login to post a reply